Literature DB >> 9867111

Oxidative stress in the liver and biliary tract diseases.

J Fehér1, G Lengyel, A Blázovics.   

Abstract

Oxidative stress plays an important role in the pathogenesis of toxic liver diseases and of other hepatic alterations. We summarize the pathomechanism of free radical reactions in liver diseases and the results of experimental and clinical observations. Most of the hepatoprotective drugs belong in the group of free-radical scavengers, their mechanism of action involving membrane stabilization, neutralization of free radicals and immunomodulation. We demonstrate the effects of the different drugs used in the therapy of liver diseases in animal experiments and in human clinicopharmacological studies. The scavenger effect of these drugs has been demonstrated in the subcellular fractions of liver cells in animal experiments. In vitro incubation with some hepatoprotective drugs inhibit lectin-induced lymphocyte transformation while others decrease the antibody-dependent, spontaneous, and lectin-induced lymphocytotoxicity. Dihydroquinolin-type antioxidants and silymarin enhanced the superoxide dismutase activity of erythrocytes and lymphocytes. In addition, in a 6-month double-blind clinical trial of patients with chronic alcoholic liver disease, we studied the effects of silymarin therapy on liver function tests, on the parameters characterizing the oxidative stress and immune reaction, on serum procollagen III peptide level, and on liver histology. A wide range of methods was used. The silymarin preparate corrected the altered immune reaction and the decreased superoxide-dismutase activity of erythrocytes and lymphocytes in patients with alcoholic liver cirrhosis. The results indicate that these drugs exert hepatoprotective activity and can improve liver functions in alcoholic patients and in toxic liver diseases. We found a correlation between the bilirubin concentration and lipid peroxidation in cases with toxic liver and biliary tract diseases, and assume that there are two kinds of bilirubin, an antioxidant and a prooxidant form, on the basis of diene conjugates in the bile.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9867111     DOI: 10.1080/003655298750026543

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  11 in total

1.  Antioxidative status of patients with alcoholic liver disease in southeastern Taiwan.

Authors:  Ya-Ling Chen; Li-Ju Chen; Ming-Jong Bair; Mei-Lan Yao; Hsiang-Chi Peng; Sien-Sing Yang; Suh-Ching Yang
Journal:  World J Gastroenterol       Date:  2011-02-28       Impact factor: 5.742

2.  Edaravone, an ROS scavenger, ameliorates photoreceptor cell death after experimental retinal detachment.

Authors:  Mi In Roh; Yusuke Murakami; Aristomenis Thanos; Demetrios G Vavvas; Joan W Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-01       Impact factor: 4.799

3.  Dose-related effects of dexamethasone on liver damage due to bile duct ligation in rats.

Authors:  Halil Eken; Hayrettin Ozturk; Hulya Ozturk; Huseyin Buyukbayram
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

4.  Hepatoprotective effects of the nitric oxide donor isosorbide-5-mononitrate alone and in combination with the natural hepatoprotectant, silymarin, on carbon tetrachloride-induced hepatic injury in rats.

Authors:  Omar Mohamed E Abdel Salam; Amany A Sleem; Nermeen Shafee
Journal:  Inflammopharmacology       Date:  2010-01-14       Impact factor: 4.473

5.  Acute transient hepatocellular injury in cholelithiasis and cholecystitis without evidence of choledocholithiasis.

Authors:  Chen-Wang Chang; Wen-Hsiung Chang; Ching-Chung Lin; Cheng-Hsin Chu; Tsang-En Wang; Shou-Chuan Shih
Journal:  World J Gastroenterol       Date:  2009-08-14       Impact factor: 5.742

Review 6.  The environmental pollutant, polychlorinated biphenyls, and cardiovascular disease: a potential target for antioxidant nanotherapeutics.

Authors:  Prachi Gupta; Brendan L Thompson; Banrida Wahlang; Carolyn T Jordan; J Zach Hilt; Bernhard Hennig; Thomas Dziubla
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

7.  Microarray analysis of hepatic gene expression in gallstone-susceptible and gallstone-resistant mice.

Authors:  Patricia A Dyck; Farzana Hoda; Elizabeth S Osmer; Richard M Green
Journal:  Mamm Genome       Date:  2003-09       Impact factor: 2.957

8.  The role of liver biopsy in detection of hepatic oxidative stress.

Authors:  Mahmoud Rushdi Abd Ellah
Journal:  Vet Med Int       Date:  2011-02-14

9.  Oxidized low-density-lipoprotein accumulation is associated with liver fibrosis in experimental cholestasis.

Authors:  Güldeniz Karadeniz; Serefden Acikgoz; Ishak Ozel Tekin; Oge Tascýlar; Banu Dogan Gun; Mustafa Cömert
Journal:  Clinics (Sao Paulo)       Date:  2008-08       Impact factor: 2.365

Review 10.  Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases.

Authors:  A Rambaldi; B P Jacobs; C Gluud
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.